Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported IBO revenue for 2026-06-30 was $10.0K. Net income was -$3.0M. Revenue was up 42.9% from 2026-03-31 to 2026-06-30. IBO currently screens at market cap $7.6M.
Use this IBO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IBO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IBO SEC filings page. Lician reads the product cache first so this HTML stays unique to Impact BioMedical, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full IBO income, balance, and cash tables.